Mike Klein

Mike Klein is an accomplished leader in pharmaceutical development with extensive experience in CMC roles across multiple organizations. Currently serving as Senior Vice President of CMC at ADAXION Therapeutics, Mike guides the development of novel therapeutics. Previously, Mike held key positions at Attralus, Nektar Therapeutics, Agenus, and Atara Biotherapeutics, focusing on analytical development, quality control, and strategic CMC operations. A Ph.D. graduate in Biological Chemistry from UCLA, Mike's early academic achievements were built upon a foundation in Biochemistry and Interdepartmental Studies from the University of Rochester. Mike's career showcases a strong track record in technical leadership, regulatory compliance, and successful technology transfers within the biotechnology sector.